ProfessionalDiscontinued

Paul Grof, MD, FRCPC Endorses Healthcare Practitioner Access to Psilocybin for Professional Training

TheraPsil’s page presents a letter from Paul Grof, MD, FRCPC supporting healthcare practitioner access to psilocybin for professional training. It explains the need for trained clinicians in psilocybin-assisted psychotherapy and the role of experiential learning in that training model.

Provider

Therapsil

English

Schedule

60 years

Enrollment

Price on request

Decision Summary

Best fit
Healthcare professionals involved in psilocybin-assisted psychotherapy, including doctors, therapists, clinical counselors, nurses, and social workers.
Format
Not listed
Time commitment
60 years
Credential signal
Not listed

Course Overview

This course page centers on a public letter from Paul Grof, MD, FRCPC, supporting healthcare practitioner access to psilocybin for professional training. The source text describes psilocybin-assisted psychotherapy as a modality that requires specific preparation and familiarity with non-ordinary states of consciousness. The page explains TheraPsil’s training approach, which combines lectures, case studies, readings, discussions, and experiential learning. In the described model, trainees include doctors, therapists, clinical counselors, nurses, social workers, and other healthcare professionals who may participate in psilocybin-assisted psychotherapy training. The page also provides background on TheraPsil’s efforts to secure exemptions for professional training and the shortage of qualified healthcare professionals in this area. It is a professional education resource focused on training rationale and access rather than a detailed standalone syllabus.

Who is this for?

Healthcare professionals involved in psilocybin-assisted psychotherapy, including doctors, therapists, clinical counselors, nurses, and social workers.

Prerequisites

Not stated.

About the Provider

TheraPsil is a Canadian grassroots nonprofit advancing compassionate, legal access to psilocybin-assisted psychotherapy through clinician training, patient advocacy, and legal reform, having trained over 700 healthcare professionals since 2019. The organization assists Canadians in navigating Health Canada's Special Access Program, supports patient-rights litigation in Federal Court, and operates the PsilWell community-funded clinical trial exploring psilocybin-assisted therapy for general wellbeing.

View all Therapsil courses

Course FAQ

Who is this course for?

Healthcare professionals involved in psilocybin-assisted psychotherapy, including doctors, therapists, clinical counselors, nurses, and social workers.

Are there prerequisites?

Not stated.

What is the format and time commitment?

Time commitment: 60 years.

How much does it cost?

This listing does not have a public price yet. Check the provider website for current tuition, fees, or application-based pricing.

Is this course currently available?

The current listing status is Discontinued. Use the provider website for the latest enrollment status.

Related Courses

View all courses